Vertically integrated cephalosporin antibiotics maker - from fermentation intermediates to APIs to finished dosage formulations.
Price
Market Cap
Sector
Healthcare
Rank
| Line item | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 | FY26 |
|---|---|---|---|---|---|---|---|---|
| LiabilitiesEquity Capital | 41 | 41 | 41 | 41 | 51 | 51 | 51 | 51 |
| Reserves | 725 | 612 | 607 | 648 | 1.1k | 1.2k | 1.2k | 1.2k |
| Borrowings | 566 | 453 | 268 | 331 | 135 | 175 | 282 | 363 |
| Other Liabilities | 128 | 132 | 195 | 205 | 249 | 246 | 167 | 261 |
| Total Liabilities | 1.5k | 1.2k | 1.1k | 1.2k | 1.6k | 1.7k | 1.7k | 1.9k |
| AssetsFixed Assets | 858 | 670 | 584 | 573 | 620 | 633 | 631 | 692 |
| CWIP | 26 | 7 | 10 | 46 | 31 | 81 | 120 | 341 |
| Investments | 0 | 15 | 45 | 44 | 46 | 50 | 49 | 53 |
| Other Assets | 576 | 544 | 472 | 561 | 857 | 925 | 922 | 826 |
| Total Assets | 1.5k | 1.2k | 1.1k | 1.2k | 1.6k | 1.7k | 1.7k | 1.9k |
| Line item | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| ActivitiesCash from Operating | 12 | 81 | 24 | 92 | 18 | 126 | 19 | 101 |
| Cash from Investing | 45 | 167 | 67 | 113 | -31 | -312 | -27 | -285 |
| Cash from Financing | 0 | -250 | -165 | -217 | 31 | 167 | 25 | 170 |
| SummaryCapital Expenditure | — | — | — | — | — | — | — | — |
| Free Cash Flow | 5 | 77 | 23 | 238 | -8 | 61 | -131 | -273 |
| FCF Margin | — | — | — | — | — | — | — | — |
This looks cyclical, and we don't have enough quarters to establish a through-cycle earnings base. Valuing it off the current point in the cycle would be misleading.
ORCHPHARMA · CYCLICAL_UNMODELABLE
Guides on how to read this kind of business and the numbers that matter.